Vimarsana
Biggest News Aggregation in the World

Page 18 - Full Year News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Full Year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Full Year Today - Breaking & Trending Today

AvalonBay Communities, Inc. Announces First Quarter 2024 Operating Results and Second Quarter and Full Year 2024 Financial Outlook - Vimarsana News

AvalonBay Communities, Inc. Announces First Quarter 2024 Operating Results and Second Quarter and Full Year 2024 Financial Outlook

AvalonBay Communities, Inc. (the "Company") reported Earnings per Share ? diluted ("EPS"), Funds from Operations attributable to common stockholders - diluted ("FFO") per share and Core FFO per share (as defined in this release) for the three months...

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50% - Vimarsana News

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

26.04.2024 - NOV Inc. (NYSE: NOV) today reported first quarter 2024 revenues of $2.16 billion, an increase of 10 percent compared to the first quarter of 2023. Net income was $119 million, or 5.5 percent of sales, a decrease of $7 million compared to the first ...

Payfare Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Payfare Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results

/PRNewswire/ - Payfare Inc. ("Payfare" or the "Company") (TSX: PAY) (OTCQX: PYFRF), a leading fintech powering instant payout and digital banking solutions for...

Eurofins Scientific : Q1 2024 Trading Update Presentation - Vimarsana News

Eurofins Scientific : Q1 2024 Trading Update Presentation

CONFIDENTIAL AND PROPRIETARY - © Eurofins Scientific Ltd, 2024. All rights reserved. This document contains information that is confidential and proprietary to Eurofins Scientific SE...

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates - Vimarsana News

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date ...